Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836))

Stephen J. Clarke; Sonia Yip; Chris Brown; Guy A. Van Hazel; David T. Ransom; David Goldstein; G. Mark Jeffrey; Niall C. Tebbutt; Martin Buck; Raymond M. Lowenthal; Amy Boland; Val Gebski; John Zalcberg; R. John Simes

doi:10.1016/j.ejca.2011.12.001

Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836))

Stephen J. Clarke
, Sonia Yip
, Chris Brown
, Guy A. Van Hazel
, David T. Ransom
, David Goldstein
, G. Mark Jeffrey
, Niall C. Tebbutt
, Martin Buck
, Raymond M. Lowenthal
, Amy Boland
, Val Gebski
, John Zalcberg
, R. John Simes

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Pages (from-to)	407
Number of pages	1
Journal	European Journal of Cancer
Volume	48
Issue number	3
DOIs	https://doi.org/10.1016/j.ejca.2011.12.001
Publication status	Published - Feb 2012
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.ejca.2011.12.001

Cite this

Clarke, S. J., Yip, S., Brown, C., Van Hazel, G. A., Ransom, D. T., Goldstein, D., Mark Jeffrey, G., Tebbutt, N. C., Buck, M., Lowenthal, R. M., Boland, A., Gebski, V., Zalcberg, J., & John Simes, R. (2012). Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836)). European Journal of Cancer, 48(3), 407. https://doi.org/10.1016/j.ejca.2011.12.001

Clarke, Stephen J. ; Yip, Sonia ; Brown, Chris et al. / Erratum : Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836)). In: European Journal of Cancer. 2012 ; Vol. 48, No. 3. pp. 407.

@article{319b1f35791c4f28982d075f3980c311,

title = "Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836))",

author = "Clarke, \{Stephen J.\} and Sonia Yip and Chris Brown and \{Van Hazel\}, \{Guy A.\} and Ransom, \{David T.\} and David Goldstein and \{Mark Jeffrey\}, G. and Tebbutt, \{Niall C.\} and Martin Buck and Lowenthal, \{Raymond M.\} and Amy Boland and Val Gebski and John Zalcberg and \{John Simes\}, R.",

year = "2012",

month = feb,

doi = "10.1016/j.ejca.2011.12.001",

language = "English",

volume = "48",

pages = "407",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier",

number = "3",

}

Clarke, SJ, Yip, S, Brown, C, Van Hazel, GA, Ransom, DT, Goldstein, D, Mark Jeffrey, G, Tebbutt, NC, Buck, M, Lowenthal, RM, Boland, A, Gebski, V, Zalcberg, J & John Simes, R 2012, 'Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836))', European Journal of Cancer, vol. 48, no. 3, pp. 407. https://doi.org/10.1016/j.ejca.2011.12.001

Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836)). / Clarke, Stephen J.; Yip, Sonia; Brown, Chris et al.
In: European Journal of Cancer, Vol. 48, No. 3, 02.2012, p. 407.

Research output: Contribution to journal › Comment / Debate › Other › peer-review

TY - JOUR

T1 - Erratum

T2 - Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836))

AU - Clarke, Stephen J.

AU - Yip, Sonia

AU - Brown, Chris

AU - Van Hazel, Guy A.

AU - Ransom, David T.

AU - Goldstein, David

AU - Mark Jeffrey, G.

AU - Tebbutt, Niall C.

AU - Buck, Martin

AU - Lowenthal, Raymond M.

AU - Boland, Amy

AU - Gebski, Val

AU - Zalcberg, John

AU - John Simes, R.

PY - 2012/2

Y1 - 2012/2

UR - https://www.scopus.com/pages/publications/84856219192

U2 - 10.1016/j.ejca.2011.12.001

DO - 10.1016/j.ejca.2011.12.001

M3 - Comment / Debate

AN - SCOPUS:84856219192

SN - 0959-8049

VL - 48

SP - 407

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 3

ER -

Clarke SJ, Yip S, Brown C, Van Hazel GA, Ransom DT, Goldstein D et al. Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836)). European Journal of Cancer. 2012 Feb;48(3):407. doi: 10.1016/j.ejca.2011.12.001

Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836))

UN SDGs

Access to Document

Other files and links

Single-agent irinotecan or FOLFIRI as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis

Cite this